Childhood Nail Psoriasis: A Useful Treatment with Tazarotene 0.05
: Nail psoriasis occurs in 7% to 40% of children, with a similar pattern of clinical presentation to that of adults. In 0.6% to 2.3% of the patients nail changes appear as the only sign of the disease, preceding other skin and articular involvement. No pediatric clinical trials are available yet, b...
Gespeichert in:
| Veröffentlicht in: | Pediatric dermatology 2007-05, Vol.24 (3), p.332-333 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 333 |
|---|---|
| container_issue | 3 |
| container_start_page | 332 |
| container_title | Pediatric dermatology |
| container_volume | 24 |
| creator | DILUVIO, LAURA CAMPIONE, ELENA PATERNÒ, EVELIN J. MORDENTI, CRISTINA HACHEM, MAYA EL CHIMENTI, SERGIO |
| description | : Nail psoriasis occurs in 7% to 40% of children, with a similar pattern of clinical presentation to that of adults. In 0.6% to 2.3% of the patients nail changes appear as the only sign of the disease, preceding other skin and articular involvement. No pediatric clinical trials are available yet, but considering the successful use of tazarotene for nail dystrophy therapy in adults, we chose this drug to treat a child. |
| doi_str_mv | 10.1111/j.1525-1470.2007.00421.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_746156763</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70582090</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4661-928537bce1be09752fe4b43e57bd6bcd75c9225f12edcbb0dd5809b4ac7aef293</originalsourceid><addsrcrecordid>eNqNkF1v0zAUQC0E2sq2v4DyAjwlXDv-iBEvVdkKUjUqrdP2ZtnOjeqSNsNOtY5fT0qr7Q3hF1vyOb7WISSjUNBhfVoVVDCRU66gYACqAOCMFrtXZPR88ZqMQJUyr4DLU_I2pRUAVFLSE3JKleCs0npExpNlaOtl19XZtQ1tNk9dDDaF9DkbZ7cJm22bLSLafo2bPnsM_TJb2N82dj1uMIMCxDl509g24cVxPyO3V5eLybd89mP6fTKe5Z4PQ3PNKlEq55E6BK0Ea5A7XqJQrpbO10p4zZhoKMPaOwd1LSrQjluvLDZMl2fk4-Hdh9j92mLqzTokj21rN9htk1FcUiGVLAfyw79JEBUDDQNYHUAfu5QiNuYhhrWNT4aC2Yc2K7PvafY9zT60-Rva7Ab13XHG1q2xfhGPZQfg_RGwydu2iXbjQ3rhKqUV43Tgvhy4x9Di039_wMy_Xg6HQc8Pekg97p51G38aqUolzN311MymN3f38_srw8o_Dy-mdQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70582090</pqid></control><display><type>article</type><title>Childhood Nail Psoriasis: A Useful Treatment with Tazarotene 0.05</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>DILUVIO, LAURA ; CAMPIONE, ELENA ; PATERNÒ, EVELIN J. ; MORDENTI, CRISTINA ; HACHEM, MAYA EL ; CHIMENTI, SERGIO</creator><creatorcontrib>DILUVIO, LAURA ; CAMPIONE, ELENA ; PATERNÒ, EVELIN J. ; MORDENTI, CRISTINA ; HACHEM, MAYA EL ; CHIMENTI, SERGIO</creatorcontrib><description>: Nail psoriasis occurs in 7% to 40% of children, with a similar pattern of clinical presentation to that of adults. In 0.6% to 2.3% of the patients nail changes appear as the only sign of the disease, preceding other skin and articular involvement. No pediatric clinical trials are available yet, but considering the successful use of tazarotene for nail dystrophy therapy in adults, we chose this drug to treat a child.</description><identifier>ISSN: 0736-8046</identifier><identifier>EISSN: 1525-1470</identifier><identifier>DOI: 10.1111/j.1525-1470.2007.00421.x</identifier><identifier>PMID: 17542899</identifier><identifier>CODEN: PEDRDQ</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Biological and medical sciences ; Child ; Dermatologic Agents - therapeutic use ; Dermatology ; Female ; General aspects ; Humans ; Medical sciences ; Nail Diseases - drug therapy ; Nicotinic Acids - therapeutic use ; Psoriasis - drug therapy ; Psoriasis. Parapsoriasis. Lichen</subject><ispartof>Pediatric dermatology, 2007-05, Vol.24 (3), p.332-333</ispartof><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4661-928537bce1be09752fe4b43e57bd6bcd75c9225f12edcbb0dd5809b4ac7aef293</citedby><cites>FETCH-LOGICAL-c4661-928537bce1be09752fe4b43e57bd6bcd75c9225f12edcbb0dd5809b4ac7aef293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1525-1470.2007.00421.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1525-1470.2007.00421.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18797241$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17542899$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DILUVIO, LAURA</creatorcontrib><creatorcontrib>CAMPIONE, ELENA</creatorcontrib><creatorcontrib>PATERNÒ, EVELIN J.</creatorcontrib><creatorcontrib>MORDENTI, CRISTINA</creatorcontrib><creatorcontrib>HACHEM, MAYA EL</creatorcontrib><creatorcontrib>CHIMENTI, SERGIO</creatorcontrib><title>Childhood Nail Psoriasis: A Useful Treatment with Tazarotene 0.05</title><title>Pediatric dermatology</title><addtitle>Pediatr Dermatol</addtitle><description>: Nail psoriasis occurs in 7% to 40% of children, with a similar pattern of clinical presentation to that of adults. In 0.6% to 2.3% of the patients nail changes appear as the only sign of the disease, preceding other skin and articular involvement. No pediatric clinical trials are available yet, but considering the successful use of tazarotene for nail dystrophy therapy in adults, we chose this drug to treat a child.</description><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Dermatologic Agents - therapeutic use</subject><subject>Dermatology</subject><subject>Female</subject><subject>General aspects</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Nail Diseases - drug therapy</subject><subject>Nicotinic Acids - therapeutic use</subject><subject>Psoriasis - drug therapy</subject><subject>Psoriasis. Parapsoriasis. Lichen</subject><issn>0736-8046</issn><issn>1525-1470</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkF1v0zAUQC0E2sq2v4DyAjwlXDv-iBEvVdkKUjUqrdP2ZtnOjeqSNsNOtY5fT0qr7Q3hF1vyOb7WISSjUNBhfVoVVDCRU66gYACqAOCMFrtXZPR88ZqMQJUyr4DLU_I2pRUAVFLSE3JKleCs0npExpNlaOtl19XZtQ1tNk9dDDaF9DkbZ7cJm22bLSLafo2bPnsM_TJb2N82dj1uMIMCxDl509g24cVxPyO3V5eLybd89mP6fTKe5Z4PQ3PNKlEq55E6BK0Ea5A7XqJQrpbO10p4zZhoKMPaOwd1LSrQjluvLDZMl2fk4-Hdh9j92mLqzTokj21rN9htk1FcUiGVLAfyw79JEBUDDQNYHUAfu5QiNuYhhrWNT4aC2Yc2K7PvafY9zT60-Rva7Ab13XHG1q2xfhGPZQfg_RGwydu2iXbjQ3rhKqUV43Tgvhy4x9Di039_wMy_Xg6HQc8Pekg97p51G38aqUolzN311MymN3f38_srw8o_Dy-mdQ</recordid><startdate>200705</startdate><enddate>200705</enddate><creator>DILUVIO, LAURA</creator><creator>CAMPIONE, ELENA</creator><creator>PATERNÒ, EVELIN J.</creator><creator>MORDENTI, CRISTINA</creator><creator>HACHEM, MAYA EL</creator><creator>CHIMENTI, SERGIO</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>200705</creationdate><title>Childhood Nail Psoriasis: A Useful Treatment with Tazarotene 0.05</title><author>DILUVIO, LAURA ; CAMPIONE, ELENA ; PATERNÒ, EVELIN J. ; MORDENTI, CRISTINA ; HACHEM, MAYA EL ; CHIMENTI, SERGIO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4661-928537bce1be09752fe4b43e57bd6bcd75c9225f12edcbb0dd5809b4ac7aef293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Dermatologic Agents - therapeutic use</topic><topic>Dermatology</topic><topic>Female</topic><topic>General aspects</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Nail Diseases - drug therapy</topic><topic>Nicotinic Acids - therapeutic use</topic><topic>Psoriasis - drug therapy</topic><topic>Psoriasis. Parapsoriasis. Lichen</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DILUVIO, LAURA</creatorcontrib><creatorcontrib>CAMPIONE, ELENA</creatorcontrib><creatorcontrib>PATERNÒ, EVELIN J.</creatorcontrib><creatorcontrib>MORDENTI, CRISTINA</creatorcontrib><creatorcontrib>HACHEM, MAYA EL</creatorcontrib><creatorcontrib>CHIMENTI, SERGIO</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Pediatric dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DILUVIO, LAURA</au><au>CAMPIONE, ELENA</au><au>PATERNÒ, EVELIN J.</au><au>MORDENTI, CRISTINA</au><au>HACHEM, MAYA EL</au><au>CHIMENTI, SERGIO</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Childhood Nail Psoriasis: A Useful Treatment with Tazarotene 0.05</atitle><jtitle>Pediatric dermatology</jtitle><addtitle>Pediatr Dermatol</addtitle><date>2007-05</date><risdate>2007</risdate><volume>24</volume><issue>3</issue><spage>332</spage><epage>333</epage><pages>332-333</pages><issn>0736-8046</issn><eissn>1525-1470</eissn><coden>PEDRDQ</coden><abstract>: Nail psoriasis occurs in 7% to 40% of children, with a similar pattern of clinical presentation to that of adults. In 0.6% to 2.3% of the patients nail changes appear as the only sign of the disease, preceding other skin and articular involvement. No pediatric clinical trials are available yet, but considering the successful use of tazarotene for nail dystrophy therapy in adults, we chose this drug to treat a child.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>17542899</pmid><doi>10.1111/j.1525-1470.2007.00421.x</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0736-8046 |
| ispartof | Pediatric dermatology, 2007-05, Vol.24 (3), p.332-333 |
| issn | 0736-8046 1525-1470 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_746156763 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Biological and medical sciences Child Dermatologic Agents - therapeutic use Dermatology Female General aspects Humans Medical sciences Nail Diseases - drug therapy Nicotinic Acids - therapeutic use Psoriasis - drug therapy Psoriasis. Parapsoriasis. Lichen |
| title | Childhood Nail Psoriasis: A Useful Treatment with Tazarotene 0.05 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T22%3A35%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Childhood%20Nail%20Psoriasis:%20A%20Useful%20Treatment%20with%20Tazarotene%200.05&rft.jtitle=Pediatric%20dermatology&rft.au=DILUVIO,%20LAURA&rft.date=2007-05&rft.volume=24&rft.issue=3&rft.spage=332&rft.epage=333&rft.pages=332-333&rft.issn=0736-8046&rft.eissn=1525-1470&rft.coden=PEDRDQ&rft_id=info:doi/10.1111/j.1525-1470.2007.00421.x&rft_dat=%3Cproquest_cross%3E70582090%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70582090&rft_id=info:pmid/17542899&rfr_iscdi=true |